Literature DB >> 3964848

Oligodendroglioma and cerebral cavernous angioma. Case report.

C P Chee, R Johnston, D Doyle, P Macpherson.   

Abstract

The authors report a case of frontal lobe oligodendroglioma associated with a cavernous angioma. The patient presented with signs and symptoms of raised intracranial pressure. Computerized tomography with contrast enhancement failed to detect the vascular component. The clinical and pathological significance of the presence of this vascular malformation in an oligodendroglioma is discussed.

Entities:  

Mesh:

Year:  1985        PMID: 3964848     DOI: 10.3171/jns.1985.62.1.0145

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Case report: glioblastoma multiforme complicating familial cavernous malformations.

Authors:  D M Wilson; B Cohen; K Keshari; H Vogel; G Steinberg; W Dillon
Journal:  Clin Neuroradiol       Date:  2013-08-14       Impact factor: 3.649

Review 2.  Cavernous angioma associated with oligo-astrocytoma-like proliferation. Report of two cases and review of the literature with a reappraisal of the term "angioglioma".

Authors:  L Palma; L Mastronardi; P Celli; R d'Addetta
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Anaplastic oligo-astrocytoma occurring after resection of a cerebral cavernous malformation; malignant transformation? Case report and review on etiology.

Authors:  Tobien Schreuder; Merijn Te Lintelo; Bela Kubat; Peter Koehler
Journal:  J Neurol       Date:  2009-09-24       Impact factor: 4.849

4.  Cerebral cavernous malformations (cavernomas) in the pediatric age-group.

Authors:  C Mazza; R Scienza; A Beltramello; R Da Pian
Journal:  Childs Nerv Syst       Date:  1991-06       Impact factor: 1.475

5.  Glioblastoma Multiforme Associated with Arteriovenous Malformation: A Case Report and Literature Review.

Authors:  Thara Tunthanathip; Kanet Kanjanapradit
Journal:  Ann Indian Acad Neurol       Date:  2020 Jan-Feb       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.